During the pandemic, it has become increasingly evident that people with cardiovascular disease and obesity are at a much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet in Sweden have identified some metabolic processes that SARS-CoV-2 uses to attack lung tissue. The results, which are published in Molecular & Cellular Proteomics, could one day be used to treat COVID-19, and potentially for other viruses like the Crimean-Congo hemorrhagic fever virus and HIV-1.
The corona pandemic, caused by the SARS-CoV-2 virus, has given rise to a serious and ongoing global health crisis. Most people who fall ill with the disease develop mild to moderate symptoms; however, patients with metabolic disorders such as diabetes, cardiovascular diseases, and obesity are at higher risk of serious illness.
